Small molecular inhibitors or monoclonal antibodies against VEGF have been used to inhibit the glioma growth, such as PTK/ZK (a VEGF receptor tyrosine kinase inhibitor), and Avastin (a monoclonal antibody against VEGF-A) [1,2]. This evidence concerns the gene VEGFA and glioma.